Chronic Viral Hepatitis in Thalassemic Liver Disease: A Long‐Term Study in Patients with Acute Hepatitis with Nontransfusion‐Dependent Thalassemia Minor

Abstract. To evaluate the effective role of hepatitis viruses in thalassemic (Th) liver disease, we carried out a long‐term study in 42 subjects with nontransfusion‐dependent Th minor hospitalized for an episode of acute viral hepatitis. 10 patients had serologic evidence of hepatitis A, 23 of hepatitis B and 9 of hepatitis non‐A, non‐B. In the follow‐up chronic hepatitis was detected histologically in 5/23 patients with hepatitis B and 5/9 with hepatitis non‐A, non‐B. All hepatitis A patients recovered completely. The prevalence in 7 out of 10 patients with chronic hepatitis of piecemeal necrosis and of inflammatory changes over hepatic siderosis and fibrosis evidenced a determinant role of chronic viral infection in the development of liver damage in these patients. Thus, heterozygous nontransfusion‐dependent Th patients seem to have a high risk of developing a chronic inflammatory liver disease especially after an episode of non‐A, non‐B hepatitis. Therefore, in our geographical area, chronic hepatitis of viral origin should be taken into account, among other pathogenetic factors, in many cases of cryptogenic thalassemic liver disease.

[1]  E. Lustbader,et al.  Serum iron levels and response to hepatitis B virus. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[2]  S. De Virgiliis,et al.  Chronic liver disease in transfusion-dependent thalassaemia: hepatitis B virus marker studies. , 1980, Journal of clinical pathology.

[3]  J. Rakela,et al.  Chronic liver disease after acute non-A, non-B viral hepatitis. , 1979, Gastroenterology.

[4]  E. Rachmilewitz,et al.  Non‐Specific Serum Iron in Thalassaemia: an Abnormal Serum Iron Fraction of Potential Toxicity , 1978, British journal of haematology.

[5]  R. Purcell,et al.  Serologic Evidence of Hepatitis A and B Virus Infections in Thalassemia Patients: A Retrospective Study , 1978, Transfusion.

[6]  G. Frösner,et al.  Prevalence of hepatitis A and B infections in multiply transfused thalassaemic patients. , 1978, British medical journal.

[7]  K. Ishak,et al.  Development of chronic liver disease after acute non-A, non-B post-transfusion hepatitis. Role of gamma-globulin prophylaxis in its prevention. , 1977, Gastroenterology.

[8]  R. Koretz,et al.  Post-transfusion chronic liver disease. , 1976, Gastroenterology.

[9]  G. Masera,et al.  Role of chronic hepatitis in development of thalassaemic liver disease. , 1976, Archives of disease in childhood.

[10]  D. Flynn,et al.  Transfusional iron overload: The relationship between tissue iron concentration and hepatic fibrosis in thalassaemia , 1975, The Journal of pathology.

[11]  D. Flynn,et al.  Long-term Chelation Therapy in Thalassaemia Major: Effect on Liver Iron Concentration, Liver Histology, and Clinical Progress , 1974, British medical journal.

[12]  R. Greenman,et al.  DNA Polymerase Associated with Human Hepatitis B Antigen , 1973, Journal of virology.

[13]  D. Flynn,et al.  The relation between liver iron concentration and liver damage in transfusional iron overload in thalassaemia and the effect of chelation therapy. , 1973, Gut.

[14]  A. Sutnick,et al.  Australia Antigen and Antibody in Transfused Children with Thalassaemia* , 1972, Archives of disease in childhood.

[15]  J. de Groote,et al.  A classification of chronic hepatitis. , 1968, Lancet.

[16]  J. de Groote Classification of Chronic Hepatitis. , 1976, Annals of clinical research.